Category: "Cannabis Derived Medicine"

FDA warns drug manufacturer marketing CBD products

PLEASE BEWARE – DON’T SELF MEDICATE WITH OVER THE COUNTER CBD PRODUCTS/CLAIMS – EpilepsyU The July 31 warning letter reflects FDA’s continuing concern over the marketing of CBD products—including supplements—to treat diseases like cancer and schizophrenia without agency drug approval. For the fourth year in a row, FDA delivered at least one warning letter related […]

Medical cannabis ‘safe’ for severe childhood epilepsy

Australian Study Shows – A small but significant group had a notable reduction in their seizures lmost all of the first 40 children given cannabidiol for severe epilepsy in Australia had an adverse event within three months — although most were mild and unrelated to the therapy, according to a study. Although four children withdrew from […]

Here’s how cannabis harms the brain

Here’s how cannabis harms the brain

It is already known that heavy, regular cannabis use increases the risk of developing mental health problems including psychosis and schizophrenia. The long-term use of either cannabis or cannabis-based drugs harms the brain, impairing memory, a new study has found. The study, led by Ana Sebastiao in collaboration with Neil Dawson and his team at […]

CBDs Enabling Improvements In Treatment Resistant Epilepsy

CBDs Enabling Improvements In Treatment Resistant Epilepsy

Evidence has been just been released revealing that CBD oils can significantly improve seizure frequency, symptoms and other measures of efficacy in patients suffering with treatment resistant epilepsy, as published in the journal Epilepsy and Behavior. Results of this study from researchers at the University of Alabama indicate use of CBD oil reduced adverse events […]

GW Pharma Reveals Epidiolex Pricing

GW Pharma Reveals Epidiolex Pricing

GW Pharmaceutical released financials for its fiscal 2018 Q3 after the close today and hosted a conference call for investors and analysts. Readers can access a full transcript provided courtesy of Seeking Alpha. As the company nears the launch of its cannabis-derived treatment for seizures in patients with rare forms of epilepsy, the investor community […]

RECENT NEWS